The objective of the present study was to compare left ventricular (LV) function and clinical outcomes in diabetics versus nondiabetics with acute myocardial infarction (AMI) treated by primary coronary angioplasty.
AMI, early recanalization of the culprit artery is of vital importance for the preservation of cardiac function and patient prognosis. 4) One way to achieve this is primary coronary angioplasty, now widely recognized as a useful and effective therapeutic strategy, and one associated with a good outcome for the patient. 5, 6) However, it is still uncertain whether DM might influence the deterioration of left ventricular systolic function. Therefore, the objective of the present study was to determine whether there is a relationship between DM and patient prognosis as well as left-ventricular function in patients with AMI treated by primary coronary angioplasty.
METHODS

Patient population:
The study population consisted of 327 consecutive patients (222 males, 105 females, mean, 69 ± 12 years, range, 35-96) with AMI who were admitted within 10 hours of onset and enrolled between January 2000 and April 2004. A diagnosis of AMI was made on the basis of the following criteria: (1) complaint of chest pain and/or discomfort; (2) electrocardiographic ST segment elevation of ≥ 0.1 mV in two or more limb leads, or ≥ 0.2 mV in two or more precordial leads, or new left bundle branch block; and (3) elevated total serum creatine kinase more than twice the upper limit of the normal range for the patient. We excluded patients found to have renal failure on admission (defined as serum creatinine levels > 3.0 mg/dL) and patients who could not be reperfused by primary coronary intervention (PCI) within 12 hours after onset. One hundred and four patients had DM while the remaining 223 patients were nondiabetic (non-DM). Among the DM patients, 26 were in need of insulin therapy, 50 were treated with an oral hypoglycemic agent, and 28 were treated by diet and/or exercise therapy only. We distinguished between within-24 hour angina pectoris before onset of AMI from overall angina pectoris in order to take into account the existence of ischemic preconditioning. All patients were followed-up for six months. The endpoint of the study was a major complication during this period, such as another myocardial infarction, the need for coronary artery bypass grafting (CABG) and/ or target vessel revascularization (TVR), or cardiac mortality. Definitions: DM was confirmed if one or more of the following criteria were met: (1) treatment with insulin or an oral hypoglycemic agent or both; (2) fasting blood glucose levels ≥ 126 mg/dL and casual blood glucose levels of 200 mg/dL or over; and (3) either a fasting or casual blood sugar level higher than the above values and a hemoglobin A1C level of 6.5% or higher. A diagnosis of DM was made on the seventh day after AMI onset. Restenosis was defined as 50% or more diameter stenosis on 6 month follow-up angiography. In the chronic phase, an indication for TVR or PCI to another coronary artery which still had significant Blood sampling: Twenty-four hours after onset, blood samples were taken from all subjects while supine. Levels of brain natriuretic peptide (BNP), atrial natriuretic peptide (ANP), renin, epinephrine, norepinephrine, and aldosterone were all assessed from the same blood samples. The concentrations of these peptides are reported to peak about 24 hours after the onset of an acute myocardial infarction, 7, 8) which is why the blood samples were obtained at that time. Highly sensitive C-reactive protein (hs-CRP) was evaluated on admission, and at 24 and 48 hours after onset. Creatine kinase (CK) was serially determined every 4 hours after admission for a period of 3 days. The peak values of these CK levels (peak-CK) were taken to reflect infarct size. Measurement of hemodynamics and cardiac function: Left ventriculograms were conducted in all subjects, from a single-plane with a right anterior deviation of 30° at the acute (soon after recanalization) and chronic (6 ± 1 months after onset) phases to evaluate left-ventricular ejection fraction (LVEF) and the left-ventricular end-diastolic volume index (LVEDVI), using the area-length method, and to evaluate regional wall motion (RWM), using the center-line method. 9) The differences between the parameters at the two stages (chronic stage -acute stage) were expressed as delta-LVEF, delta-LVEDVI, and delta-RWM. We excluded posterior infarctions from our evaluation because of the associated issue of inaccuracy. We also evaluated left ventricular end-diastolic pressure (LVEDP) at two separate stages. The Rentrop classification was used to evaluate collateral circulation before recanalization, and the Thrombolysis In Myocardial Infarction (TIMI) classification was used to evaluate epicardial coronary flow. On admission, the Killip classification was used to assess the severity of the patient's condition. ECG analysis: ST-segment elevation was measured 0.08 seconds after the J point. The sum of ST-segment elevations (Σ ST) was obtained from leads I, aVL, and V 1 through V 6 for left anterior descending artery occlusions and from leads II, III, aVF, V 5 , V 6 , and reciprocal ST segment depressions in V 1 and V 2 for right coronary artery and left circumflex artery occlusions. Σ ST was calculated from two separate 12-lead ECG recordings, one just prior to and one at the conclusion of coronary intervention. ST segment analysis was performed by a single observer blinded to the clinical data. A reduction of at least 50% in the Σ ST segment elevation between the pre-and post-PCI ECGs was considered to constitute significant ST segment resolution. Statistical analysis: Values are expressed as the mean ± standard deviation (SD). All statistical tests were two-tailed, and a P value < 0.05 was considered statistically significant. The cut-off points of the concentrations of cardiovascular peptides, peak hs-CRP, and peak-CK were chosen based on tertiles in the overall ( ) = % [continuous values expressed as mean ± SD] OMI = history of old myocardial infarction; Angina within 24 hours = existence of preinfarction angina pectoris within 24 hours of onset; Time elapsed = time from onset to reperfusion; BNP = brain natriuretic peptide; ANP = atrial natriuretic peptide; Hs-CRP on admission = highly sensitive C-reactive protein on admission; Peak hs-CRP = maximum value of highly sensitive C-reactive protein; Peak CK = maximum value of creatine kinase.
Vol 46 No 4 sample. Univariate and multivariate logistic regression analyses were performed, with the independent variables assessed including age, gender, diabetes mellitus, culprit lesion location, number of vessels involved, Killip classification on admission (≥ II, on admission), elapsed time, spontaneous recanalization, ANP, BNP, peak-hs-CRP, and peak-CK value. The odds ratios and 95% confidence intervals were also calculated.
RESULTS
The clinical characteristics and laboratory findings for the DM group and non-DM group are summarized in Table I . There were no significant differences − ( ) = % [continuous values expressed as mean ± SD]. HR = heart rate; Systolic BP = systolic blood pressure; ST resolution = A reduction of at least 50% in the Σ ST segment elevation between the pre-and post-PCI ECGs was considered significant ST segment elevation resolution; Culprit vessel = coronary artery responsible for acute myocardial infarction; LMT = left main trunk; LAD = left anterior descending artery; RCA = right coronary artery; LCX = left circumflex coronary artery; collateral circulation = good collateral circulation (Rentrop grade II or III); spontaneous recanalization = TIMI 2 or 3 before intervention therapy; use of coronary stent = cases in which a coronary stent was used; TIMI 3 after angioplasty = TIMI 3 coronary flow soon after coronary angioplasty. Other abbreviations as in Table I. in age, gender, coronary risk factors, previous myocardial infarction, existence of angina pectoris within 24 hours, or elapsed time. There were also no significant differences in peak CK values, BNP, ANP, highly-sensitive-CRP, renin, aldosterone, or catecholamines between the two groups. Thus, it was concluded that the baseline characteristics between the two groups were similar.
Hemodynamic data at the time of admission and angiographical results in the acute phase are shown in Table II . There were no significant differences in heart rate or systolic blood pressure between the two groups. In terms of the clinical severity of heart failure on admission, there were also no significant differences in Killip classification between the two groups. There were no significant differences in terms of culprit vessel, the existence of spontaneous recanalization (TIMI II or III), good collateral circulation (Rentrop grade II or III), or the rate of use of coronary stents between the two groups. However, there was a significantly higher incidence of patients with multivessel disease in the DM group than in the non-DM group (53% versus 39%, P = 0.02). We observed significantly more patients who failed to get TIMI 3 flow after primary coronary angioplasty in the DM group than in the non-DM group (88% versus 96%, P < 0.05). Further- Acute phase = soon after recanalization; Chronic phase = 6 ± 1 month after onset; LVEDP = left-ventricular end-diastolic pressure; LVEDVI = left-ventricular end-diastolic volume index; RWM = regional wall motion; LVEF = left-ventricular ejection fraction; delta LVEDVI = differences in LVEDVI between two phases; delta RWM = differences in RWM between two phases; delta LVEF = differences in LVEF between two phases; Other abbreviations as in Table I.  Vol 46  No 4 more, in terms of ST segment elevation resolution, there were significantly fewer patients who showed significant ST segment resolution in the DM group than in the non-DM group (59% versus 83%, P < 0.0001). Table III shows left-ventricular function in the acute and chronic phases. In the acute stage (soon after recanalization), there were no significant differences in LVEDP, LVEDVI, RWM, or LVEF. In the chronic stage (6 ± 1 month after onset), there were no significant differences in LVEDP or LVEDVI, however, LVEF was significantly lower in the DM group than in the non-DM group (52 ± 14% versus 58 ± 13%, P = 0.001). RWM was slightly lower in the DM group than in the non-DM group, however, the difference was not statistically significant. Delta LVEDVI was slightly larger in the DM group compared with the non-DM group, however, this was also not statistically significant. Furthermore, the delta LVEF and delta RWM values were significantly worse in the DM group compared with the non-DM group (delta EF: 1 ± 9% versus 7 ± 10%, P < 0.0001, delta RWM: 0.6 ± 1.2 SD/chord versus 1.1 ± 1.4 SD/chord, P = 0.04).
Major complications observed in the first 6 months are shown in Table IV . In terms of clinical severity, significantly more DM patients required CABG (10% versus 5%, P < 0.05) and more DM patients required target lesion revascularization (29% versus 19%, P < 0.05) than non-DM patients.
The follow-up period for this study was 6 months. Twenty-one patients died from cardiovascular causes during the follow-up period; heart failure in 16, cardiac rupture in 3, and sudden death out of hospital in two cases. Only 9 of these patients were in the non-DM group, with the other 12 patients were in the DM group. This constitutes a significantly higher mortality rate for the DM group than the non-DM group (12% versus 4%, P = 0.01). ( ) = %, PCI to other coronary = percutaneous coronary intervention therapy to other coronary artery which had remaining significant stenosis was required. Cardiac rupture = patients with cardiac rupture; Re-MI = re-attack of myocardial infarction; CABG = coronary artery bypass grafting; TVR = target vessel revascularization. Table V shows the predictors of cardiac death in our AMI patients during a six month period since onset. According to multivariate analysis, DM was identified as an independent predictor of cardiac death (odds ratio 5.5, 95% CI, 1.3-23.7, P < 0.05), as was the BNP value and being female.
Deterioration of the left ventricular ejection fraction was defined as a delta-LVEF < 0. Excluding patients who had a posterior infarction, a total of 241 Tables I  to IV . patients (DM: 65 patients, non-DM: 176 patients) could undergo left ventriculograms at both the acute and chronic stages. In the DM group, there were significantly more patients with deterioration of the left ventricular ejection fraction than non-DM patients (43% versus 17%, P < 0.001). Multivariate analysis also identified DM as a sole independent predictor of deterioration of the left ventricular ejection fraction (odds ratio 5.8, 95% CI, 2.8-11.8, P = 0.002) (Table VI) .
DISCUSSION
Immediate reperfusion of an infarct-related artery is associated with a favorable outcome in the treatment of AMI. 4) Thus, primary coronary angioplasty is an initial treatment strategy for AMI patients in current medical practice. 5, 6) Today, the prognosis for AMI has been dramatically improved by applying aggressive revascularization strategies followed by proper coronary care unit management. 5, 6) However, AMI patients with DM still have a poor prognosis. [1] [2] [3] They are frequently susceptible to poor prognostic conditions such as reinfarction, 10) the need for target vessel revascularization (TVR), 11) and heart failure. 12, 13) Furthermore, there have been several reports on the relationship between DM and cardiac death in AMI patients, [1] [2] [3] 14) while on the other hand, some researchers have reported conflicting results with respect to whether the presence of DM becomes a predictor of mortality in AMI. 11, 15) Yet, it is still unclear whether there is a clear relationship between DM and cardiac mortality in AMI patients.
In the current study, which focused on a series of 327 AMI patients (including 104 DM patients), the DM patients tended to experience more heart failure, TVR, and coronary artery bypass grafting (CABG) during the six month followup period. Furthermore, multivariate analysis revealed DM was an independent predictor of cardiac death.
On the other hand, the baseline characteristics of patients have been reported to be factors related to a poor prognosis in DM patients. 1) However, statistically significant differences in the baseline characteristics of age, sex, risk factors, and the presence of old myocardial infarction were not observed in the current study. It is well known that the hemodynamics of a patient upon admission affect the clinical outcome of AMI. In our study, however, there were no significant differences in heart rate, systolic blood pressure, or Killip classification on admission between the DM and non-DM groups. Therefore, it was possible to assume that the degrees of severity of AMI at the time of admission were similar between the DM and non-DM patients in our study. The results of laboratory tests performed during an acute phase that showed no significant differences in the levels of BNP, ANP, catecholamines, peak-CK values, and peak-hs-CRP also suggested infarction size and the degree of heart failure were similar in the two groups. However, patients with DM were less likely to reach TIMI 3 flow after primary coronary angioplasty. Furthermore, they were more likely to experience a major adverse cardiac event, such as the need for TVR or CABG, heart failure, and cardiac death during the follow-up period. These poor outcomes may have been provoked by the contribution of several factors, such as an already damaged coronary microvascular circulation, 16) increased procedural risk for atherothrombotic embolism, 17) and endothelial dysfunction, 18) together with a more extensive disease profile in the diabetic patients. 19) These factors are related to the progression of coronary atherosclerotic change.
Dccreased cardiac function in AMI patients with DM has been reported to induce the deterioration of LVEF, 20, 21) lead to left ventricular (LV) remodeling, 22) and result in a poor LV ejection fraction (EF) in the chronic phase. 23) On the other hand, it has also been reported that impaired cardiac function in AMI patients with DM does not affect LV systolic function 24) and LV remodeling. 13) Still to this day, no consensus has been reached on this point.
In the present study, patients in the DM group exhibited poor LVEF in the chronic phase even though both groups had similar LV systolic functions in the acute phase. Furthermore, the results of multivariate analysis showed that DM was the only independent predictor of the deterioration of delta-LVEF. Another study 25) found that hospitalization is often delayed in AMI patients with DM because their symptoms are masked as a result of neuropathy caused by the LV dysfunction. In the present study, however, no significant difference was observed in the time from onset to reperfusion between the DM and non-DM patients because we excluded patients without chest pain or discomfort and patients who were not admitted to hospital within 10 hours of AMI onset. Primary coronary angioplasty was conducted equally in all patients in both groups, including the frequency of coronary stent usage. However, patients in the DM group were less likely to attain TIMI 3 coronary flow after angioplasty. Also, we observed significantly more patients who failed to show ST-segment resolution in the DM group than in the non-DM group. Previous reports 26, 27) have suggested that the absence of early ST-segment resolution after successful primary PCI identifies patients who are less likely to benefit from recanalization of the infarctrelated artery since these patients are likely to have sustained greater microvascular injury and consequently have less salvageable myocardium. There may indeed be a close relationship between DM and microvascular injury. Hence, patients with DM suffering from this microvascular disorder were less likely to achieve TIMI 3 flow despite an aggressive treatment strategy for recanalization. Furthermore, it is conceivable that although coronary angiography after angioplasty indicated the attainment of TIMI 3 flow, AMI patients with DM were less likely to have favorable reperfusion at the microcirculation level. Furthermore, in the Vol 46 No 4 present study, significantly more patients in the DM group required CABG and/ or TVR in the chronic phase than in the non-DM group. This residual myocardial ischemia may have affected LV systolic dysfunction in the chronic phase. LVEF deterioration in patients with DM may be provoked by this microcirculation dysfunction and the several factors mentioned above, even though similar LV systolic functions were observed in the acute phase.
The results of the present study indicate that AMI patients with DM cannot always necessarily be expected to receive sufficient myocardial protection and have a good outcome like other non-DM patients, even though early reperfusion therapy may be performed. Thus, more prudent attention should be paid when managing AMI patients with DM compared to those without DM. Study limitations: There are a number of limitations to the present study. First, the small study population means that our results require confirmation in a largerscale trial before any concrete conclusions can be drawn. Second, we excluded patients with renal failure because these patients are unable to tolerate primary coronary angioplasty. This may have introduced bias into the study protocol and results. Third, we did not differentiate between anterior and inferior infarctions in our evaluation of left-ventricular systolic function, which also may have resulted in bias. Fourth, our evaluation of LVEF deterioration did not take into account LVEDVI or RWM. Conclusion: In AMI patients treated with primary coronary angioplasty, DM is closely related to left-ventricular systolic dysfunction and a poor patient outcome, including mortality.
DM was also identified as an independent predictor of mortality and deterioration of left ventricular ejection fraction in these AMI patients.
